Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fish roe oil, derived from the eggs of fish such as salmon and herring, is rich in omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These fatty acids are known for their beneficial effects on cardiovascular and metabolic health. Several clinical and preclinical studies have investigated the role of omega-3s in addressing components of metabolic syndrome, which include central obesity, dyslipidemia, hypertension, and insulin resistance.

A number of randomized controlled trials and meta-analyses support the ability of omega-3 supplementation to lower triglyceride levels, reduce inflammation, and improve endothelial function—factors relevant to metabolic syndrome. For example, a 2019 review in Frontiers in Endocrinology highlighted the triglyceride-lowering and anti-inflammatory effects of fish-derived omega-3s. However, direct studies on fish roe oil specifically are limited; most clinical research uses fish body oil. Some preliminary studies suggest that fish roe oil may have a similar or even superior bioavailability and lipid profile compared to standard fish oil, but confirmatory large-scale trials are lacking.

In summary, while the broader class of marine omega-3s is supported by moderate-quality evidence for improving certain aspects of metabolic syndrome, direct evidence for fish roe oil itself is more limited but promising. Its use is justified based on extrapolation from the well-established benefits of marine omega-3 fatty acids.

More about Fish roe oil
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Fish roe oil

Products containing Fish roe oil